REFERENCES:
Abdallah, H., Wintermans, B., Reuland, E., Koek, A., Al Naiemi, N., Ammar, A., . . . Vandenbroucke-Grauls, C. (2015). Extended-spectrum β-lactamase-and carbapenemase-producing Enterobacteriaceae isolated from egyptian patients with suspected blood stream infection. PloS one, 10 (5), e0128120.
Abe, R., Oda, S., Sadahiro, T., Nakamura, M., Hirayama, Y., Tateishi, Y., . . . Hirasawa, H. (2010). Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia.Critical Care, 14 (2), 1-7.
Al-Agamy, M. H., Shibl, A. M., & Tawfik, A. F. (2009). Prevalence and molecular characterization of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Annals of Saudi medicine, 29 (4), 253.
Amer, W. H., Khalil, H. S., & Abd EL Wahab, M. (2016). Risk factors, phenotypic and genotypic characterization of carbapenem resistant Enterobacteriaceae in Tanta University Hospitals, Egypt. Int J Infect Control, 12 (2), 1-11.
America, I. D. S. o. (2011). Combating antimicrobial resistance: policy recommendations to save lives. Clinical Infectious Diseases, 52 (suppl_5), S397-S428.
Bassetti, M., Merelli, M., Temperoni, C., & Astilean, A. (2013). New antibiotics for bad bugs: where are we? Annals of Clinical Microbiology and Antimicrobials, 12 (1), 22. doi:10.1186/1476-0711-12-22
Bauer, A. (1966). Antibiotic susceptibility testing by a standardized single disc method. Am J clin pathol, 45 , 149-158.
Bell, B. G., Schellevis, F., Stobberingh, E., Goossens, H., & Pringle, M. (2014). A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC infectious diseases, 14 (1), 13.
Bookstaver, P., Nimmich, E., Smith, T., Justo, J., Kohn, J., Hammer, K., . . . Al-Hasan, M. (2017). Cumulative effect of an antimicrobial stewardship and rapid diagnostic testing bundle on early streamlining of antimicrobial therapy in gram-negative bloodstream infections.Antimicrobial agents and chemotherapy, 61 (9), e00189-00117.
Buising, K., Thursky, K., Robertson, M., Black, J., Street, A., Richards, M., & Brown, G. (2008). Electronic antibiotic stewardship—reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting.Journal of Antimicrobial Chemotherapy, 62 (3), 608-616.
Cantón, R., Horcajada, J. P., Oliver, A., Garbajosa, P. R., & Vila, J. (2013). Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance.Enfermedades infecciosas y microbiologia clinica, 31 , 3-11.
Conway, E. L., Sellick, J. A., Horey, A., Fodero, K., Ott, M. C., Krajewski, M. P., & Mergenhagen, K. A. (2017). Decreased mortality in patients prescribed vancomycin after implementation of antimicrobial stewardship program. American journal of infection control, 45 (11), 1194-1197.
Costelloe, C., Metcalfe, C., Lovering, A., Mant, D., & Hay, A. D. (2010). Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. Bmj, 340 .
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., . . . Wilcox, M. (2013). Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database of Systematic Reviews (4).
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., . . . Carpenter, C. F. (2007). Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical Infectious Diseases, 44 (2), 159-177.
Doane, D. P., & Seward, L. E. (2011). Measuring skewness: a forgotten statistic? Journal of statistics education, 19 (2).
El Kholy, A., & El Manakhly, A. (2018). 2300. Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Causing Central Line Associated Blood Stream Infections (CLABSI) in Three ICU Units in Egypt. Paper presented at the Open Forum Infectious Diseases.
Elligsen, M., Walker, S. A., Pinto, R., Simor, A., Mubareka, S., Rachlis, A., . . . Daneman, N. (2012). Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients a controlled interrupted time series analysis. Infection Control & Hospital Epidemiology, 33 (4), 354-361.
Hanberger, H., Skoog, G., Ternhag, A., & Giske, C. G. (2014). Antibiotic consumption and antibiotic stewardship in Swedish hospitals.Upsala Journal of Medical Sciences, 119 (2), 154-161.
Hansen, D. S., Aucken, H. M., Abiola, T., & Podschun, R. (2004). Recommended test panel for differentiation of Klebsiella species on the basis of a trilateral interlaboratory evaluation of 18 biochemical tests. Journal of clinical microbiology, 42 (8), 3665-3669.
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., . . . Facilities, P. N. H. S. N. (2008). Antimicrobial‐resistant pathogens associated with healthcare‐associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infection control and hospital epidemiology, 29 (11), 996-1011.
Horikoshi, Y., Suwa, J., Higuchi, H., Kaneko, T., Furuichi, M., Aizawa, Y., . . . Shoji, T. (2017). Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality.International Journal of Infectious Diseases, 64 , 69-73.
In, C. (2018). Performance standards for antimicrobial susceptibility testing: Wayne, PA: Clinical and Laboratory Standards Institute.
Jaggi, N., Sissodia, P., & Sharma, L. (2012). Impact of antimicrobial stewardship programme on carbapenem resistance in gram negative isolates in an Indian tertiary care hospital. American Journal of Infectious Diseases, 8 (2), 106-111.
Khalifa, H. O., Soliman, A. M., Ahmed, A. M., Shimamoto, T., Nariya, H., Matsumoto, T., & Shimamoto, T. (2019). High prevalence of antimicrobial resistance in gram-negative Bacteria isolated from clinical settings in Egypt: recalling for judicious use of conventional antimicrobials in developing nations. Microbial Drug Resistance, 25 (3), 371-385.
Lesprit, P., Landelle, C., & Brun-Buisson, C. (2013). Clinical impact of unsolicited post-prescription antibiotic review in surgical and medical wards: a randomized controlled trial. Clinical microbiology and infection, 19 (2), E91-E97.
Lindsay, P. J., Rohailla, S., Taggart, L. R., Lightfoot, D., Havey, T., Daneman, N., . . . Muller, M. P. (2019). Antimicrobial stewardship and intensive care unit mortality: a systematic review. Clinical Infectious Diseases, 68 (5), 748-756.
Liu, J., Wang, H., Huang, Z., Tao, X., Li, J., Hu, Y., . . . Zou, M. (2019). Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients. The Journal of Infection in Developing Countries, 13 (05), 357-364.
Maeda, M., Takuma, T., Seki, H., Ugajin, K., Naito, Y., Yoshikawa, M., . . . Shoji, H. (2016). Effect of interventions by an antimicrobial stewardship team on clinical course and economic outcome in patients with bloodstream infection. Journal of Infection and Chemotherapy, 22 (2), 90-95.
McNulty, C. A. (2012). European Antibiotic Awareness Day 2012: general practitioners encouraged to TARGET antibiotics through guidance, education and tools. Journal of antimicrobial chemotherapy, 67 (11), 2543-2546.
Melake, N. A., Mahmoud, A. B., Elraghy, N. A., Labib, A. Z., Hassan, D. M., & Elbrolosy, A. M. (2016). Detection of Klebsiella pneumoniae carbapenemases and metallo-β-lactamases among Klebsiella pneumoniae isolates from hospitalized patients at Menoufia University Hospitals, Egypt. Menoufia Medical Journal, 29 (4), 801.
Metwally, L., Gomaa, N., Attallah, M., & Kamel, N. (2013). High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt. Eastern Mediterranean Health Journal, 19 (11).
Nowak, M. A., Nelson, R. E., Breidenbach, J. L., Thompson, P. A., & Carson, P. J. (2012). Clinical and economic outcomes of a prospective antimicrobial stewardship program. American Journal of Health-System Pharmacy, 69 (17), 1500-1508.
Prabaker, K., & Weinstein, R. A. (2011). Trends in antimicrobial resistance in intensive care units in the United States. Current opinion in critical care, 17 (5), 472-479.
Razali, N. M., & Wah, Y. B. (2011). Power comparisons of shapiro-wilk, kolmogorov-smirnov, lilliefors and anderson-darling tests. Journal of statistical modeling and analytics, 2 (1), 21-33.
Rimawi, R. H., Mazer, M. A., Siraj, D. S., Gooch, M., & Cook, P. P. (2013). Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Critical care medicine, 41 (9), 2099-2107.
Shapiro, S. S., & Wilk, M. B. (1965). An analysis of variance test for normality (complete samples). Biometrika, 52 (3/4), 591-611.
Sherry, N., & Howden, B. (2018). Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam–epidemiology, laboratory detection and treatment implications. Expert review of anti-infective therapy, 16 (4), 289-306.
Shorr, A. F., Zilberberg, M. D., Micek, S. T., & Kollef, M. H. (2014). Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study. BMC infectious diseases, 14 (1), 572.
Shu, L.-b., Lu, Q., Sun, R.-h., Lin, L.-q., Sun, Q.-l., Hu, J., . . . Zhang, R. (2019). Prevalence and phenotypic characterization of carbapenem-resistant Klebsiella pneumoniae strains recovered from sputum and fecal samples of ICU patients in Zhejiang Province, China.Infection and drug resistance, 12 , 11.
Simmons, M., Sherman, B., & Crosmun, C. (2016). Decrease in Daily Defined Doses of Carbapenems Using Minimal Impact Interventions, Suppression of Sensitivities and Utilization. Paper presented at the Open Forum Infectious Diseases.
Sketris, I. S., Metge, C. J., Ross, J. L., MacCara, M. E., Comeau, D. G., Kephart, G. C., & Blackburn, J. L. (2004). The use of the World Health Organisation anatomical therapeutic chemical/defined daily dose methodology in Canada. Drug information journal: DIJ/Drug Information Association, 38 (1), 15-27.
Solomon, D. H., Van Houten, L., Glynn, R. J., Baden, L., Curtis, K., Schrager, H., & Avorn, J. (2001). Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Archives of internal medicine, 161 (15), 1897-1902.
Solomon, S. L., & Oliver, K. B. (2014). Antibiotic resistance threats in the United States: stepping back from the brink. American family physician, 89 (12), 938-941.
Srinivasan, A. (2017). Antibiotic stewardship: why we must, how we can.Cleveland Clinic journal of medicine, 84 (9), 673.
Van De Sande-Bruinsma, N., Grundmann, H., Verloo, D., Tiemersma, E., Monen, J., Goossens, H., . . . System, E. A. R. S. (2008). Antimicrobial drug use and resistance in Europe. Emerging infectious diseases, 14 (11), 1722.
Vincent, J.-L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C. D., . . . Sakr, Y. (2009). International study of the prevalence and outcomes of infection in intensive care units. JAMA, 302 (21), 2323-2329.
Yong, M., Buising, K. L., Cheng, A., & Thursky, K. (2010). Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. Journal of Antimicrobial Chemotherapy, 65 (5), 1062-1069.
Yuan, Y., Wang, J., Yao, Z., Ma, B., Li, Y., Yan, W., . . . Xu, J. (2020). Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes. Infection and drug resistance, 13 , 207.